Molecular Target Synopsis
Overview
Domains and Structures
Drugs and Clinical Candidates
Druggability
Chemistry
Ligand Efficiency Plot
Pathways
Family Cladogram
Interaction Network
Gene Expression
Gene Copy Number Variation
RNAi
Mutations
Germline Genetics

glvI (Q7NDN8) - Domains And Structures - Molecular Target Synopsis

Click Here to View Molecular Target 3D Synopsis

Select a homology cutoff:
Structural Sequence Similarity Matches
Domains Covered Gene Name (Uniprot) Solved in Complex with Organism PDB Chain Identity E-Value Resolution Ligands Release Date
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MVN_A 100 0 3.49Å LMT PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3IGQ_B 100 0 2.3Å - 2009-12-08
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HEH_E 100 0 3.3Å - 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MZT_C 100 0 2.65Å LMT PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYZ_E 100 0 3.05Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F13_B 100 0 2.7Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYA_C 100 0 3.39Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F10_A 100 0 2.85Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU4_D 100 0 3.05Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0M_E 100 0 2.65Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HCM_B 100 0 3.15Å - 2016-04-13
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0I_D 100 0 3Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6I08_D 100 0 3Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0U_D 100 0 2.35Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ7_E 100 0 3.4Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UUB_C 100 0 2.9Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MUR_A 100 0 3.1Å PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ILC_B 100 0 2.99Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZ0_C 100 0 2.75Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5NJY_B 100 0 2.95Å - 2018-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU4_A 100 0 3.05Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ILB_B 100 0 3.15Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5L4H_D 100 0 3.3Å LMT 2016-12-21
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0R_E 100 0 2.5Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_N 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQA_A 100 0 3.6Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5NKJ_A 100 0 3.2Å - 2018-06-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6EMX_E 100 0 3.2Å - 2018-06-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4QH4_C 100 0 3.2Å LMT 2015-07-22
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5L4E_A 100 0 3.5Å D12 2016-12-21
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) Gabra2 (P26048), glvI (Q7NDN8) - MOUSE, SUNBITTERN 5OSA_C 100 0 2.75Å Y01 D12 2017-10-11
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 6HY5_D 100 0 2.58Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HY9_A 100 0 2.95Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UUB_E 100 0 2.9Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4IL9_E 100 0 2.83Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ZZC_D 100 0 3.1Å LMT PLC 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F12_B 100 0 3.2Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F16_A 100 0 2.6Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - MOUSE 5OSC_B 100 0 2.97Å Y01 A8W 2017-10-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0V_A 100 0 2.85Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HEG_D 100 0 3.2Å - 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_D 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MZR_B 100 0 2.65Å LMT PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MUO_B 100 0 2.9Å - 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F10_D 100 0 2.85Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 6HYR_C 100 0 3.5Å SCH 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4QH1_C 100 0 3.39Å - 2015-03-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZ1_E 100 0 2.5Å PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HCJ_A 100 0 2.95Å LMT 2016-04-13
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFB_B 100 0 2.75Å PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F15_E 100 0 2.85Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_J 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU8_D 100 0 3.25Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3P4W_B 100 0 3.2Å LMT DSF PLC 2011-01-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFE_A 100 0 2.8Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFC_A 100 0 3.05Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLS_C 100 0 3.2Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFD_B 100 0 3.1Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0R_C 100 0 2.5Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0M_D 100 0 2.65Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UUB_D 100 0 2.9Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_F 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ6_C 100 0 3.7Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MUO_A 100 0 2.9Å LMT 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MZR_C 100 0 2.65Å LMT PFL PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU8_E 100 0 3.25Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFC_B 100 0 3.05Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6I08_C 100 0 3Å PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5L4E_E 100 0 3.5Å - 2016-12-21
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZ3_D 100 0 3.1Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0J_C 100 0 3Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU5_B 100 0 2.9Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_E 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 5V6N_D 100 0 3.355Å LMT 2017-10-18
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ7_A 100 0 3.4Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYA_B 100 0 3.39Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4QH5_A 100 0 3Å LMT 2015-03-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ILA_D 100 0 3.5Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0I_E 100 0 3Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HCM_A 100 0 3.15Å - 2016-04-13
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5L47_A 100 0 2.99Å - 2016-12-21
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3P4W_E 100 0 3.2Å LMT DSF PLC 2011-01-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZ1_B 100 0 2.5Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3P50_E 100 0 3.3Å LMT PFL PLC 2011-01-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MVN_B 100 0 3.49Å LMT PFL PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4LMJ_A 100 0 3.44Å - 2013-10-30
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_M 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 5V6N_A 100 0 3.355Å LMT 2017-10-18
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLV_E 100 0 2.9Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F16_E 100 0 2.6Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HCJ_D 100 0 2.95Å - 2016-04-13
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5IUX_E 100 0 2.6Å PC1 LMT 2017-03-29
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 6HYR_B 100 0 3.5Å SCH 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0Z_C 100 0 2.5Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYV_E 100 0 2.8Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - MOUSE 5OSC_A 100 0 2.97Å Y01 A8W 2017-10-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4QH4_D 100 0 3.2Å LMT 2015-07-22
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ3_E 100 0 3.5Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MZQ_E 100 0 2.8Å PC8 D12 2IL 2018-02-28
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU6_C 100 0 2.98Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU5_C 100 0 2.9Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4IL4_E 100 0 3.3Å LSM 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HEG_C 100 0 3.2Å - 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYZ_B 100 0 3.05Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MZQ_B 100 0 2.8Å PC8 D12 2IL 2018-02-28
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ9_E 100 0 3.2Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0U_E 100 0 2.35Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5NKJ_D 100 0 3.2Å - 2018-06-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYX_C 100 0 3Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F15_D 100 0 2.85Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F12_C 100 0 3.2Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3EAM_E 100 0 2.9Å PC1 LMT 2008-11-04
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4QH1_D 100 0 3.39Å - 2015-03-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFB_E 100 0 2.75Å PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HY9_B 100 0 2.95Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU3_D 100 0 3.15Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3LSV_A 100 0 3.14Å - 2010-04-28
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3P4W_D 100 0 3.2Å DSF PLC 2011-01-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU4_C 100 0 3.05Å LMT 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6EMX_B 100 0 3.2Å - 2018-06-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4QH4_B 100 0 3.2Å LMT 2015-07-22
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F13_A 100 0 2.7Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_Q 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4F8H_E 100 0 2.99Å LMD PC1 RKE 2012-08-29
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F11_B 100 0 2.95Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0N_E 100 0 3.2Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0R_D 100 0 2.5Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ILC_C 100 0 2.99Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4QH4_E 100 0 3.2Å LMT 2015-07-22
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MVN_D 100 0 3.49Å LMT PFL PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0N_D 100 0 3.2Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HY9_C 100 0 2.95Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYZ_C 100 0 3.05Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYX_D 100 0 3Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MZR_D 100 0 2.65Å LMT PFL PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5L4E_C 100 0 3.5Å - 2016-12-21
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ZZB_D 100 0 3.4Å - 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4IL4_D 100 0 3.3Å LSM 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ILA_C 100 0 3.5Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5NJY_E 100 0 2.95Å - 2018-05-16
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 5V6O_E 100 0 3.12Å LMT 2017-10-18
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4LMK_C 100 0 3.22Å - 2013-10-30
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLV_C 100 0 2.9Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HCM_E 100 0 3.15Å - 2016-04-13
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5L47_B 100 0 2.99Å 6JA 2016-12-21
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYW_D 100 0 2.8Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLT_C 100 0 3.3Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0Z_A 100 0 2.5Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFD_E 100 0 3.1Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F13_C 100 0 2.7Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F15_B 100 0 2.85Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UUB_A 100 0 2.9Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4LML_E 100 0 3.8Å - 2013-10-30
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU8_B 100 0 3.25Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MVM_A 100 0 3.1Å LMT PFL PLC 2018-03-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F10_C 100 0 2.85Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 3EHZ_E 100 0 3.1Å - 2008-11-11
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 5V6N_E 100 0 3.355Å LMT 2017-10-18
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) Gabra2 (P26048), glvI (Q7NDN8) - MOUSE, SUNBITTERN 5OSA_D 100 0 2.75Å Y01 D12 2017-10-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4QH5_B 100 0 3Å LMT 2015-03-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYA_E 100 0 3.39Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLS_B 100 0 3.2Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_P 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQA_D 100 0 3.6Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFB_D 100 0 2.75Å PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLV_B 100 0 2.9Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 6HY5_B 100 0 2.58Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU5_D 100 0 2.9Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFI_E 100 0 2.4Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0V_D 100 0 2.85Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ5_E 100 0 3.5Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MUR_D 100 0 3.1Å PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ILB_C 100 0 3.15Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFH_B 100 0 2.65Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3IGQ_C 100 0 2.3Å - 2009-12-08
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3P50_B 100 0 3.3Å LMT PFL PLC 2011-01-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3LSV_B 100 0 3.14Å - 2010-04-28
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_L 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5L4H_C 100 0 3.3Å - 2016-12-21
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFH_C 100 0 2.65Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - MOUSE 5OSB_E 100 0 3.8Å A8Z 2017-10-11
Neurotransmitter-gated ion-channel ligand binding domain (1%) (view alignment) (P0C7B7), glvI (Q7NDN8) - ERWINIA CHRYSANTHEMI, PECTOBACTERIUM CHRYSANTHEMI 4YEU_D 100 0 4.6Å - 2015-09-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6I08_B 100 0 3Å PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_B 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5L4H_B 100 0 3.3Å - 2016-12-21
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFI_C 100 0 2.4Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZ3_B 100 0 3.1Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4IRE_B 100 0 3.19Å PC1 2013-04-24
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFC_C 100 0 3.05Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5IUX_D 100 0 2.6Å PC1 6E3 2017-03-29
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0M_C 100 0 2.65Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3IGQ_A 100 0 2.3Å - 2009-12-08
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6EMX_C 100 0 3.2Å - 2018-06-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZ3_E 100 0 3.1Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3EAM_A 100 0 2.9Å PC1 LMT 2008-11-04
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYV_D 100 0 2.8Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MUO_D 100 0 2.9Å PFL 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 5J0Z_A 100 0 3.25Å LMT HXA PLC 2017-03-15
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZ0_A 100 0 2.75Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYW_B 100 0 2.8Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HCM_D 100 0 3.15Å - 2016-04-13
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - MOUSE 5OSB_D 100 0 3.8Å - 2017-10-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) Gabra2 (P26048), glvI (Q7NDN8) - MOUSE, SUNBITTERN 5OSA_B 100 0 2.75Å Y01 D12 2017-10-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLT_E 100 0 3.3Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 6F7A_E 100 0 6Å - 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HEG_E 100 0 3.2Å - 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6I08_A 100 0 3Å PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU5_E 100 0 2.9Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ILA_B 100 0 3.5Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLU_A 100 0 2.85Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYX_A 100 0 3Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ7_D 100 0 3.4Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4IL4_C 100 0 3.3Å LSM 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 6HYR_D 100 0 3.5Å SCH 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYZ_D 100 0 3.05Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ6_A 100 0 3.7Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLV_D 100 0 2.9Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HY9_D 100 0 2.95Å LMT 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPP_A 100 0 3.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYA_D 100 0 3.39Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4IL9_B 100 0 2.83Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0Z_B 100 0 2.5Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU4_B 100 0 3.05Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYW_C 100 0 2.8Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HCJ_E 100 0 2.95Å - 2016-04-13
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFH_A 100 0 2.65Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_O 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU6_D 100 0 2.98Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MZR_E 100 0 2.65Å LMT PFL PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4LMK_D 100 0 3.22Å - 2013-10-30
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F11_D 100 0 2.95Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) Gabra2 (P26048), glvI (Q7NDN8) - MOUSE, SUNBITTERN 5OSA_E 100 0 2.75Å Y01 D12 2017-10-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5NKJ_E 100 0 3.2Å - 2018-06-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4LML_C 100 0 3.8Å - 2013-10-30
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0N_C 100 0 3.2Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU8_C 100 0 3.25Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MZT_D 100 0 2.65Å LMT PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLT_B 100 0 3.3Å LMT 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFI_D 100 0 2.4Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ILC_D 100 0 2.99Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (1%) (view alignment) (P0C7B7), glvI (Q7NDN8) - ERWINIA CHRYSANTHEMI, PECTOBACTERIUM CHRYSANTHEMI 4YEU_E 100 0 4.6Å - 2015-09-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5L4H_A 100 0 3.3Å - 2016-12-21
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MZR_A 100 0 2.65Å LMT PFL PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU6_A 100 0 2.98Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0M_B 100 0 2.65Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_C 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4IL4_A 100 0 3.3Å LSM 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLW_E 100 0 2.6Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HEH_A 100 0 3.3Å - 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ZZC_E 100 0 3.1Å LMT PLC 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4F8H_B 100 0 2.99Å LMD PC1 RKE 2012-08-29
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MUO_C 100 0 2.9Å - 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYW_A 100 0 2.8Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFD_A 100 0 3.1Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5IUX_C 100 0 2.6Å PC1 LMT 2017-03-29
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UUB_B 100 0 2.9Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3IGQ_D 100 0 2.3Å - 2009-12-08
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HCM_C 100 0 3.15Å LMT 2016-04-13
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZ3_C 100 0 3.1Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLU_D 100 0 2.85Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F12_A 100 0 3.2Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4QH1_B 100 0 3.39Å - 2015-03-11
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 6HY5_E 100 0 2.58Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ZZB_E 100 0 3.4Å - 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4IRE_A 100 0 3.19Å PC1 LMD 2013-04-24
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFC_D 100 0 3.05Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ILA_A 100 0 3.5Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZ1_D 100 0 2.5Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6EMX_A 100 0 3.2Å - 2018-06-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_K 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 3EI0_D 100 0 3.5Å - 2008-11-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5IUX_B 100 0 2.6Å PC1 LMT 2017-03-29
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4QH1_A 100 0 3.39Å - 2015-03-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MUR_C 100 0 3.1Å PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLU_B 100 0 2.85Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZ1_A 100 0 2.5Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F11_A 100 0 2.95Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4LMK_B 100 0 3.22Å - 2013-10-30
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F13_E 100 0 2.7Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ILB_E 100 0 3.15Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (1%) (view alignment) (P0C7B7), glvI (Q7NDN8) - ERWINIA CHRYSANTHEMI, PECTOBACTERIUM CHRYSANTHEMI 4YEU_A 100 0 4.6Å - 2015-09-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLT_D 100 0 3.3Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0J_E 100 0 3Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 3EI0_E 100 0 3.5Å - 2008-11-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F16_C 100 0 2.6Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 5V6N_C 100 0 3.355Å LMT 2017-10-18
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5NJY_C 100 0 2.95Å - 2018-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFI_B 100 0 2.4Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4LMK_A 100 0 3.22Å - 2013-10-30
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4F8H_A 100 0 2.99Å LMD PC1 RKE 2012-08-29
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MVN_E 100 0 3.49Å LMT PFL PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5L47_D 100 0 2.99Å D12 2016-12-21
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UUB_I 100 0 2.9Å PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ5_D 100 0 3.5Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4LML_B 100 0 3.8Å - 2013-10-30
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYV_C 100 0 2.8Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HY9_E 100 0 2.95Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3EAM_B 100 0 2.9Å PC1 LMT 2008-11-04
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0I_C 100 0 3Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ3_C 100 0 3.5Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5NKJ_B 100 0 3.2Å - 2018-06-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4LMJ_E 100 0 3.44Å LMT 2013-10-30
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZW_C 100 0 2.22Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4IL9_A 100 0 2.83Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ7_B 100 0 3.4Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3IGQ_E 100 0 2.3Å - 2009-12-08
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFH_D 100 0 2.65Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0V_E 100 0 2.85Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0N_B 100 0 3.2Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MUO_E 100 0 2.9Å - 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0M_A 100 0 2.65Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ6_D 100 0 3.7Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4IRE_D 100 0 3.19Å PC1 2013-04-24
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3LSV_E 100 0 3.14Å - 2010-04-28
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 3EI0_A 100 0 3.5Å - 2008-11-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU3_C 100 0 3.15Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0R_B 100 0 2.5Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (1%) (view alignment) (P0C7B7), glvI (Q7NDN8) - ERWINIA CHRYSANTHEMI, PECTOBACTERIUM CHRYSANTHEMI 4YEU_B 100 0 4.6Å - 2015-09-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5IUX_A 100 0 2.6Å PC1 6E3 LMT 2017-03-29
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_T 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ8_A 100 0 3.6Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 5V6O_D 100 0 3.12Å LMT 2017-10-18
Neurotransmitter-gated ion-channel ligand binding domain (49%) (view alignment) glvI (Q7NDN8), GLRA1 (P23415) - HUMAN 4X5T_D 100 0 3.5Å - 2015-02-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYX_B 100 0 3Å LMT 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 5V6N_B 100 0 3.355Å LMT 2017-10-18
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MVM_C 100 0 3.1Å LMT PFL PLC 2018-03-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5L4E_B 100 0 3.5Å - 2016-12-21
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MZQ_C 100 0 2.8Å PC8 D12 2IL 2018-02-28
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - MOUSE 5OSB_C 100 0 3.8Å A8Z 2017-10-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F16_B 100 0 2.6Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFD_C 100 0 3.1Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ5_A 100 0 3.5Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLU_C 100 0 2.85Å LMT 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQA_B 100 0 3.6Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4IL9_D 100 0 2.83Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 5V6O_B 100 0 3.12Å LMT 2017-10-18
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4F8H_D 100 0 2.99Å LMD PC1 RKE 2012-08-29
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UUB_H 100 0 2.9Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 6HY5_C 100 0 2.58Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYW_E 100 0 2.8Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ3_D 100 0 3.5Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3IGQ_F 100 0 2.3Å - 2009-12-08
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - MOUSE 5OSC_D 100 0 2.97Å Y01 A8W 2017-10-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0U_A 100 0 2.35Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MZQ_A 100 0 2.8Å PC8 D12 2IL 2018-02-28
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5NKJ_C 100 0 3.2Å - 2018-06-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ4_C 100 0 3.4Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQA_E 100 0 3.6Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFD_D 100 0 3.1Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ZZC_A 100 0 3.1Å LMT PLC 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F10_E 100 0 2.85Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (49%) (view alignment) glvI (Q7NDN8), GLRA1 (P23415) - HUMAN 4X5T_C 100 0 3.5Å - 2015-02-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ZZB_A 100 0 3.4Å LMT 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ILC_E 100 0 2.99Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5NJY_D 100 0 2.95Å - 2018-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLS_A 100 0 3.2Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UUB_J 100 0 2.9Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU6_B 100 0 2.98Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ9_B 100 0 3.2Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F15_C 100 0 2.85Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4IL4_B 100 0 3.3Å LSM 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLV_A 100 0 2.9Å LMT 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ4_B 100 0 3.4Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU3_A 100 0 3.15Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_A 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0I_B 100 0 3Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F13_D 100 0 2.7Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 5J0Z_D 100 0 3.25Å LMT HXA 2017-03-15
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYV_B 100 0 2.8Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HEG_B 100 0 3.2Å - 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLW_D 100 0 2.6Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - MOUSE 5OSC_E 100 0 2.97Å Y01 A8W 2017-10-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MUR_E 100 0 3.1Å PFL PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ6_E 100 0 3.7Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 3EHZ_C 100 0 3.1Å - 2008-11-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4IRE_C 100 0 3.19Å PC1 LMD 2013-04-24
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ8_B 100 0 3.6Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLU_E 100 0 2.85Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU8_A 100 0 3.25Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0N_A 100 0 3.2Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0J_D 100 0 3Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZ0_D 100 0 2.75Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4IRE_E 100 0 3.19Å PC1 LMD 2013-04-24
Neurotransmitter-gated ion-channel ligand binding domain (1%) (view alignment) (P0C7B7), glvI (Q7NDN8) - ERWINIA CHRYSANTHEMI, PECTOBACTERIUM CHRYSANTHEMI 4YEU_C 100 0 4.6Å - 2015-09-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5L47_C 100 0 2.99Å - 2016-12-21
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ3_A 100 0 3.5Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3P50_D 100 0 3.3Å LMT PFL PLC 2011-01-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPP_C 100 0 3.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZ3_A 100 0 3.1Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3P50_A 100 0 3.3Å LMT PFL PLC 2011-01-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ9_A 100 0 3.2Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 3EI0_B 100 0 3.5Å - 2008-11-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3LSV_D 100 0 3.14Å - 2010-04-28
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3P4W_A 100 0 3.2Å LMT DSF PLC 2011-01-19
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 5J0Z_B 100 0 3.25Å LMT HXA 2017-03-15
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFC_E 100 0 3.05Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F11_E 100 0 2.95Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - MOUSE 5OSB_B 100 0 3.8Å A8Z 2017-10-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ILB_D 100 0 3.15Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZW_B 100 0 2.22Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MVN_C 100 0 3.49Å LMT PFL PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ZZC_B 100 0 3.1Å LMT PLC 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (49%) (view alignment) glvI (Q7NDN8), GLRA1 (P23415) - HUMAN 4X5T_B 100 0 3.5Å - 2015-02-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - MOUSE 5OSC_C 100 0 2.97Å A8W 2017-10-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ZZB_B 100 0 3.4Å - 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU5_A 100 0 2.9Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HEG_A 100 0 3.2Å - 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZ1_C 100 0 2.5Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UUB_G 100 0 2.9Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 3EI0_C 100 0 3.5Å - 2008-11-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ4_D 100 0 3.4Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0V_C 100 0 2.85Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ3_B 100 0 3.5Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ5_B 100 0 3.5Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6I08_E 100 0 3Å PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFE_B 100 0 2.8Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3LSV_C 100 0 3.14Å - 2010-04-28
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 6F7A_C 100 0 6Å - 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4F8H_C 100 0 2.99Å LMD PC1 RKE 2012-08-29
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_G 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 5V6O_A 100 0 3.12Å LMT 2017-10-18
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0I_A 100 0 3Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3EAM_D 100 0 2.9Å PC1 2008-11-04
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4LMJ_B 100 0 3.44Å - 2013-10-30
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MVM_B 100 0 3.1Å LMT PFL PLC 2018-03-14
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 3EHZ_D 100 0 3.1Å - 2008-11-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ILB_A 100 0 3.15Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 5V6O_C 100 0 3.12Å LMT 2017-10-18
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4QH5_E 100 0 3Å LMT PLC 2015-03-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4QH1_E 100 0 3.39Å - 2015-03-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_I 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZW_E 100 0 2.22Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYV_A 100 0 2.8Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MVM_D 100 0 3.1Å LMT PLC 2018-03-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4QH4_A 100 0 3.2Å LMT 2015-07-22
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 6F7A_B 100 0 6Å - 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4QH5_C 100 0 3Å LMT PLC 2015-03-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ8_C 100 0 3.6Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU3_B 100 0 3.15Å LMT 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HEH_C 100 0 3.3Å - 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6EMX_D 100 0 3.2Å - 2018-06-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFE_E 100 0 2.8Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZW_A 100 0 2.22Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYA_A 100 0 3.39Å LMT 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 5J0Z_E 100 0 3.25Å HXA 2017-03-15
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ9_D 100 0 3.2Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFB_A 100 0 2.75Å PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0Z_D 100 0 2.5Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ4_A 100 0 3.4Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ8_E 100 0 3.6Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4LML_D 100 0 3.8Å - 2013-10-30
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - MOUSE 5OSB_A 100 0 3.8Å A8Z 2017-10-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYZ_A 100 0 3.05Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU3_E 100 0 3.15Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4IL9_C 100 0 2.83Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 3EHZ_B 100 0 3.1Å - 2008-11-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F11_C 100 0 2.95Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 6HYR_A 100 0 3.5Å LMT SCH 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_R 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLS_D 100 0 3.2Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 6HYR_E 100 0 3.5Å SCH 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HCJ_C 100 0 2.95Å - 2016-04-13
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MZT_E 100 0 2.65Å LMT PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F12_D 100 0 3.2Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MZT_A 100 0 2.65Å LMT PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLW_B 100 0 2.6Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F10_B 100 0 2.85Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4QH5_D 100 0 3Å LMT 2015-03-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ5_C 100 0 3.5Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4LMJ_D 100 0 3.44Å - 2013-10-30
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ZZB_C 100 0 3.4Å - 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MZT_B 100 0 2.65Å LMT PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0V_B 100 0 2.85Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HEH_D 100 0 3.3Å - 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPP_E 100 0 3.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4LMJ_C 100 0 3.44Å - 2013-10-30
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZ0_B 100 0 2.75Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0J_A 100 0 3Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZW_D 100 0 2.22Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5NJY_A 100 0 2.95Å - 2018-05-16
Neurotransmitter-gated ion-channel ligand binding domain (49%) (view alignment) glvI (Q7NDN8), GLRA1 (P23415) - HUMAN 4X5T_A 100 0 3.5Å - 2015-02-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3P50_C 100 0 3.3Å PFL PLC 2011-01-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3EAM_C 100 0 2.9Å PC1 LMT 2008-11-04
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HZ0_E 100 0 2.75Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (49%) (view alignment) glvI (Q7NDN8), GLRA1 (P23415) - HUMAN 4X5T_E 100 0 3.5Å - 2015-02-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F16_D 100 0 2.6Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFE_C 100 0 2.8Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 6F7A_A 100 0 6Å - 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFH_E 100 0 2.65Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ZZC_C 100 0 3.1Å LMT PLC 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFI_A 100 0 2.4Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ7_C 100 0 3.4Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F15_A 100 0 2.85Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MUR_B 100 0 3.1Å PFL PLC 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4LML_A 100 0 3.8Å - 2013-10-30
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ILC_A 100 0 2.99Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ8_D 100 0 3.6Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4LMK_E 100 0 3.22Å LMT 2013-10-30
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MVM_E 100 0 3.1Å LMT PFL PLC 2018-03-14
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 5J0Z_C 100 0 3.25Å HXA 2017-03-15
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ9_C 100 0 3.2Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UUB_F 100 0 2.9Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 6F7A_D 100 0 6Å - 2018-02-14
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5L47_E 100 0 2.99Å - 2016-12-21
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HEH_B 100 0 3.3Å - 2016-03-02
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQA_C 100 0 3.6Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5MZQ_D 100 0 2.8Å PC8 D12 2IL 2018-02-28
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0J_B 100 0 3Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (99%) (view alignment) glvI (Q7NDN8) - 6HY5_A 100 0 2.58Å LMT PLC 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFE_D 100 0 2.8Å LMT PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0U_B 100 0 2.35Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6HYX_E 100 0 3Å - 2018-12-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLW_C 100 0 2.6Å LMT 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (98%) (view alignment) glvI (Q7NDN8) - 3EHZ_A 100 0 3.1Å - 2008-11-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLW_A 100 0 2.6Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4ILA_E 100 0 3.5Å LMT PLC 2013-02-20
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0R_A 100 0 2.5Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU4_E 100 0 3.05Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ4_E 100 0 3.4Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) Gabra2 (P26048), glvI (Q7NDN8) - MOUSE, SUNBITTERN 5OSA_A 100 0 2.75Å Y01 D12 2017-10-11
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0U_C 100 0 2.35Å LMT PLC 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F0Z_E 100 0 2.5Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_H 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPP_B 100 0 3.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPP_D 100 0 3.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 6F12_E 100 0 3.2Å LMT 2018-01-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4HFB_C 100 0 2.75Å PLC 2013-04-17
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 4NPQ_S 100 0 4.35Å - 2013-12-25
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5HCJ_B 100 0 2.95Å - 2016-04-13
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3P4W_C 100 0 3.2Å LMT DSF PLC 2011-01-19
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLT_A 100 0 3.3Å - 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5L4H_E 100 0 3.3Å 6JW 2016-12-21
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 2XQ6_B 100 0 3.7Å - 2010-11-10
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3UU6_E 100 0 2.98Å LMT PLC 2012-05-16
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 5L4E_D 100 0 3.5Å EDP 2016-12-21
Neurotransmitter-gated ion-channel ligand binding domain (100%) (view alignment) glvI (Q7NDN8) - 3TLS_E 100 0 3.2Å LMT 2012-05-16